Teriparatide Shortage

The ANZBMS has released a guidance statement to support clinicians in managing patients during the current shortage of teriparatide. This statement outlines practical treatment strategies to ensure continuity of care and to help optimise bone health outcomes during this period of limited supply.

Download Guidance on the Current Teriparatide Shortage 2025.

Updated 8 Sep, 2025